Advertisement

Reactions Weekly

, Volume 1761, Issue 1, pp 299–299 | Cite as

Pembrolizumab

Various toxicities: case report
Case report

Reference

  1. Duraes J, et al. Demyelinating disease of the central nervous system associated with Pembrolizumab treatment for metastatic melanoma. Multiple Sclerosis Journal 25: 1005-1008, No. 7, Jun 2019 - PortugalGoogle Scholar

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations